Your browser doesn't support javascript.
loading
Characterization of Plasmodium ovale curtisi and P. ovale wallikeri in Western Kenya utilizing a novel species-specific real-time PCR assay.
Miller, Robin H; Obuya, Clifford O; Wanja, Elizabeth W; Ogutu, Bernhards; Waitumbi, John; Luckhart, Shirley; Stewart, V Ann.
Afiliação
  • Miller RH; Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, United States of America.
  • Obuya CO; Kondele Laboratory, U.S. Army Medical Research Unit-Kenya, Kisumu, Kenya.
  • Wanja EW; Kondele Laboratory, USAMRU-K, Kisumu, Kenya.
  • Ogutu B; Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya.
  • Waitumbi J; Walter Reed Project, Kenya Medical Research Institute, Kisumu, Kenya.
  • Luckhart S; Department of Medical Microbiology and Immunology, University of California Davis School of Medicine, Davis, California, United States of America.
  • Stewart VA; Preventive Medicine and Biometrics, Uniformed Services University, Bethesda, Maryland, United States of America.
PLoS Negl Trop Dis ; 9(1): e0003469, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25590587
ABSTRACT

BACKGROUND:

Plasmodium ovale is comprised of two genetically distinct subspecies, P. ovale curtisi and P. ovale wallikeri. Although P. ovale subspecies are similar based on morphology and geographical distribution, allelic differences indicate that P. ovale curtisi and P. ovale wallikeri are genetically divergent. Additionally, potential clinical and latency duration differences between P. ovale curtisi and P. ovale wallikeri demonstrate the need for investigation into the contribution of this neglected malaria parasite to the global malaria burden.

METHODS:

In order to detect all P. ovale subspecies simultaneously, we developed an inclusive P. ovale-specific real-time PCR assay based on conserved regions between P. ovale curtisi and P. ovale wallikeri in the reticulocyte binding protein 2 (rbp2) gene. Additionally, we characterized the P. ovale subspecies prevalence from 22 asymptomatic malaria infections using multilocus genotyping to discriminate P. ovale curtisi and P. ovale wallikeri.

RESULTS:

Our P. ovale rbp2 qPCR assay validation experiments demonstrated a linear dynamic range from 6.25 rbp2 plasmid copies/microliter to 100,000 rbp2 plasmid copies/microliter and a limit of detection of 1.5 rbp2 plasmid copies/microliter. Specificity experiments showed the ability of the rbp2 qPCR assay to detect low-levels of P. ovale in the presence of additional malaria parasite species, including P. falciparum, P. vivax, and P. malariae. We identified P. ovale curtisi and P. ovale wallikeri in Western Kenya by DNA sequencing of the tryptophan-rich antigen gene, the small subunit ribosomal RNA gene, and the rbp2 gene.

CONCLUSIONS:

Our novel P. ovale rbp2 qPCR assay detects P. ovale curtisi and P. ovale wallikeri simultaneously and can be utilized to characterize the prevalence, distribution, and burden of P. ovale in malaria endemic regions. Using multilocus genotyping, we also provided the first description of the prevalence of P. ovale curtisi and P. ovale wallikeri in Western Kenya, a region holoendemic for malaria transmission.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article